Spine biologics are used during spine fusion surgery for the treatment of spinal deformities such as trauma, tumors, degenerative disc disease, and spinal cord injuries by stimulating bone growth formation

The global anesthesia devices market was valued at $9,563 million in 2016, and is projected to reach $15,463 million by 2023, registering a CAGR of 7.1% from 2017 to 2023. The anesthesia delivery machine

The Medical nonwoven disposables market was valued at $ 7,910 million in 2017, and is projected to reach $14,134 million by 2025, growing at a CAGR of 7.4% from 2018 to 2025. The surgical product segment

The global cell-based assay market was valued at $3,625 million in 2016, and is projected to reach $10,618 million by 2023, growing at a CAGR of 16.5% from 2017 to 2023. The consumables product segment

The global respiratory care devices market was valued at $12,890 million in 2015, and is projected to reach $21,300 million by 2022, registering a CAGR of 7.4% from 2016 to 2022.The therapeutic segment

The global laparoscopy devices market was valued at $9,350 million in 2015 and is expected to garner $14,046 million by 2022, registering a CAGR of 5.8% during the forecast period 2016 - 2022. The energy

The global endoscopy devices market was valued at $30.01 billion in 2018, and is projected to reach $45.39 billion by 2026, at a CAGR of 5.4% from 2019 to 2026. The endoscope segment garnered more than

Global mHealth market was valued at $10.5 billion in 2014 and is expected to grow at a CAGR of 33.5% during 2015-2020. Mobile health provides health service and information through mobile

The Global Cancer Immunotherapy Market was valued at $45,471 million in 2015, and is projected to reach $117,114 million by 2022, growing at a CAGR of 14.5% from 2016 to 2022. The monoclonal antibodies

Global Intraoperative Neuromonitoring (IONM) Market was valued at $3,036 million in 2015, and is projected to reach $4,900 million by 2022, growing at a CAGR of 7% from 2016 to 2022, according to a new

The global biosurgery market is expected to garner $12,758.1 million by 2022, registering a CAGR of 8.1% during the period 2014 - 2022. Hemostatic and surgical sealing agents segment collectively